OncoMate MSI Dx Analysis System— 510(k) K200129
Substantially EquivalentPromega Corporation
FDA 510(k) clearance K200129 for OncoMate MSI Dx Analysis System, Substantially Equivalent on 2021-07-26. Applicant: Promega Corporation.
Clearance details
- Applicant
- Promega Corporation
- Product code
- Code PZJ
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Madison, WI, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.